Organization
Tokyo Metropolitan Institute for Geriatrics and Gerontology
8 abstracts
Abstract
Geriatric assessment in older patients with non-small cell lung cancer: Insights from a cluster-randomized, phase III trial—ENSURE-GA study (NEJ041/CS-Lung001).Org: St. Marianna University School of Medicine, Kagawa University Faculty of Medicine, Teine Keijinnkai Hospital, NHO Hamada Medical Center, Tokyo Metropolitan Institute for Geriatrics and Gerontology,
Abstract
Acquired gene alteration patterns and post-progression survival: PARADIGM study analysis.Org: National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan, Disaster Medical Center, Tokyo, Japan, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East, Kashiwa, Japan,
Abstract
Associations between prognosis and primary endpoint selection in phase III oncology trials in the United States.Org: The University of Tokyo, Tokyo, Japan, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan Association for Development of Community Medicine,
Abstract
Prognosis of squamous cell carcinoma of the breast by biological subtypes and the efficacy of radiotherapy: The Japanese Breast Cancer Registry analysis.Org: Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, The University of Tokyo Hospital, Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Kyushu University,
Abstract
A phase 1b study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in combination with lenvatinib in patients with advanced hepatocellular carcinoma.Org: National Cancer Center Hospital East, Kashiwa, Japan, Kashiwa-Shi, Japan Association for Development of Community Medicine, Graduate School of Medicine Chiba University, Chiba, Japan,
Abstract
Pirtobrutinib in covalent BTK-inhibitor (cBTKi) pre-treated mantle cell lymphoma (MCL): Updated results and subgroup analysis from the phase 1/2 BRUIN study with >3 years follow-up from start of enrollment.Org: Medical College of Wisconsin, Milwaukee, WI, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland, IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli” and Dipartimento di Medicina Specialistica,
Abstract
Pembrolizumab and ramucirumab neoadjuvant therapy for PD-L1-positive stage IB-IIIA lung cancer (EAST ENERGY).Org: Department of Thoraci surgery, National Cancer Center Hospital East, Kashiwa, Japan, Division of Thoracic and Thyroid Surgery, Tokyo Medical University, Department of Thoracic Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan,
Abstract
Effect of lymph node dissection and adjuvant therapy in patients with sentinel node+ melanoma: An observational multicenter study.Org: National Cancer Center Hospital East, Kashiwa, Japan, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan Association for Development of Community Medicine, Nagoya University Graduate School of Medicine, Aichi Cancer Center Hospital,